MedPath

methazolamide

METHAZOLAMIDE TABLETS USP 25 mg and 50 mg Rx Only

Approved
Approval ID

8395cda9-1a6d-408c-8818-4a5d90c4a4e0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 18, 2020

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

methazolamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-3233
Application NumberANDA040062
Product Classification
M
Marketing Category
C73584
G
Generic Name
methazolamide
Product Specifications
Route of AdministrationORAL
Effective DateNovember 12, 2018
FDA Product Classification

INGREDIENTS (6)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
METHAZOLAMIDEActive
Quantity: 50 mg in 1 1
Code: W733B0S9SD
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.